Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
NCT00722228

Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

Led by Hadassah Medical Organization · Updated on 2025-10-02

50

Participants Needed

1

Research Sites

965 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is based on the finding that tumor cells that are grown in the laboratory can be modified in such a way that, when injected to the patient, they will stimulate his/her immune response. This approach will be evaluated in patients with melanoma and colorectal, gastric, ovarian, breast, lung and kidney epithelial cancer. Tumor cells grown in the laboratory will be modified to make them stimulatory to the immune system, irradiated to kill them, and injected to the patient eight times at two-week intervals. This protocol is expected to prolong survival of metastatic cancer patients.

CONDITIONS

Official Title

Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have metastatic melanoma, breast, ovary, colorectal, gastric, lung, or kidney cancer
  • Are 18 years of age or older
  • Have failed at least one chemotherapy protocol
  • Have an ECOG performance status of 0 or 1
  • Have an absolute neutrophil count greater than 1000/mm3
  • Have serum ALT and AST levels less than three times the upper limit of normal
  • Have serum creatinine less than or equal to 1.6 mg/dl
  • Are able to understand and sign the informed consent document
Not Eligible

You will not qualify if you...

  • Are under 18 years of age
  • Are pregnant
  • Have a life expectancy of less than three months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hadassah Medical Organization

Jerusalem, Israel, 91120

Actively Recruiting

Loading map...

Research Team

H

Hani Steinberg, R.N. B.A.

CONTACT

T

Tamar Peretz, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here